Small-molecule inhibitors of protein-protein interactions: progressing towards the dream.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 4, p. 301, doi. 10.1038/nrd1343
- By:
- Publication type:
- Article
Works matching IS 14741776 AND DT 2004 AND VI 3 AND IP 4
Results: 21
1
2
Another long leaderless period in store for FDA.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 4, p. 289, doi. 10.1038/nrd1378
- By:
- Publication type:
- Article
3
siRNAs: applications in functional genomics and potential as therapeutics.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 4, p. 318, doi. 10.1038/nrd1345
- By:
- Publication type:
- Article
4
Targeting IL-1 in inflammatory disease: new opportunities for therapeutic intervention.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 4, p. 1, doi. 10.1038/nrd1342
- By:
- Publication type:
- Article
5
Fresh from the pipeline: Tadalafil and vardenafil.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 4, p. 295, doi. 10.1038/nrd1362
- By:
- Publication type:
- Article
6
Rat genome sequence reignites preclinicalmodel debate.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 4, p. 287, doi. 10.1038/nrd1377
- By:
- Publication type:
- Article
7
AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 4, p. 340, doi. 10.1038/nrd1344
- By:
- Publication type:
- Article
8
Mark C. Fishman.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 4, p. 292, doi. 10.1038/nrd1363
- Publication type:
- Article
9
Virtual screening: Gliding to success.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 4, p. 299, doi. 10.1038/nrd1364
- By:
- Publication type:
- Article
10
Cardiovascular disease: Ezetimibe explained?
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 4, p. 298, doi. 10.1038/nrd1367
- By:
- Publication type:
- Article
11
Inflammation: Free radicals on trial for microbicide: not guilty?
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 4, p. 298, doi. 10.1038/nrd1369
- By:
- Publication type:
- Article
12
Opinion: Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 4, p. 353, doi. 10.1038/nrd1346
- By:
- Publication type:
- Article
13
Opinion: Cutting the cost of drug development?
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 4, p. 360, doi. 10.1038/nrd1347
- By:
- Publication type:
- Article
14
Opinion: Gene patenting and medical research: a view from a pharmaceutical company.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 4, p. 364, doi. 10.1038/nrd1348
- By:
- Publication type:
- Article
15
From the analyst's couch: The Fast Track effect.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 4, p. 293, doi. 10.1038/nrd1349
- By:
- Publication type:
- Article
16
Patentability in Europe.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 4, p. 291, doi. 10.1038/nrd1350
- By:
- Publication type:
- Article
17
Cardiovascular disease: Intensive care.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 4, p. 297, doi. 10.1038/nrd1371
- By:
- Publication type:
- Article
18
Leaving the bench for the clinic.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 4, p. 371, doi. 10.1038/nrd1374
- By:
- Publication type:
- Article
19
The seven habits of highly effective drug discoverers?
- Published in:
- 2004
- Publication type:
- Editorial
20
News In Brief.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 4, p. 288, doi. 10.1038/nrd1379
- Publication type:
- Article
21
Neurodegenerative disease: Linking lipids to Alzheimer's.
- Published in:
- Nature Reviews Drug Discovery, 2004, v. 3, n. 4, p. 300, doi. 10.1038/nrd1372
- By:
- Publication type:
- Article